Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose ...
Shares of Replimune Group, Inc. (NASDAQ: NASDAQ:REPL) surged 17% following the announcement that the U.S. Food and Drug ...
(RTTNews) - ImmunityBio, Inc. (IBRX), a immunotherapy company, provided a regulatory update on its clinical development pipeline following discussions with the U.S. Food and Drug Administration or ...